Christoph Lengauer, Chief Scientific Officer at Blueprint Medicines Corp (BPMC), sold 31,744 shares at $20.01 ($635K) on 2016-04-13, disclosed to the SEC on 2016-04-14.
Open-market sale of $635k BPMC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.01 | 15,872 | $318K | 50.0% |
| 2 | $20.01 | 15,872 | $318K | 50.0% |
| Total | $20.01 avg | 31,744 | $635K | 100% |
| Filing → |
| BPMC | SELL | 2015-11-04 | $1.8M | — | Filing → |